Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $88

Benzinga · 08/07 14:40
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $84 to $88.